{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:09:14Z","timestamp":1793736554242,"version":"4.6.1"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["25PRE1374495"],"award-info":[{"award-number":["25PRE1374495"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P30GM149404"],"award-info":[{"award-number":["P30GM149404"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL174521"],"award-info":[{"award-number":["R01HL174521"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.tem.2026.05.004","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:28:32Z","timestamp":1780633712000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Glucocorticoid resistance-induced inflammation drives cardiovascular\u2013kidney\u2013metabolic (CKM) syndrome pathophysiology"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4593-7708","authenticated-orcid":false,"given":"Genesee J.","family":"Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8359-4008","authenticated-orcid":false,"given":"David E.","family":"Stec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7599-1529","authenticated-orcid":false,"suffix":"Jr","given":"Terry D.","family":"Hinds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2026.05.004_bb0005","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1042\/CS20257571","article-title":"The physiology of MASLD: molecular pathways between liver and adipose tissues","volume":"139","author":"Lee","year":"2025","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.tem.2026.05.004_bb0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11906-023-01242-8","article-title":"Mechanisms linking metabolic-associated fatty liver disease (MAFLD) to cardiovascular disease","volume":"25","author":"Badmus","year":"2023","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.tem.2026.05.004_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2026.111379","article-title":"Kinase signaling in liver disease via clinical-trial-on-a-PamChip: a distinctive methodology for drug mechanisms and personalized medicine","volume":"302","author":"Kipp","year":"2026","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2026.05.004_bb0020","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202402169R","article-title":"Insulin receptor responsiveness governs TGF\u03b2-induced hepatic stellate cell activation: insulin resistance instigates liver fibrosis","volume":"39","author":"Lee","year":"2025","journal-title":"FASEB J."},{"key":"10.1016\/j.tem.2026.05.004_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.102010","article-title":"Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation","volume":"88","author":"Muturi","year":"2024","journal-title":"Mol. Metab."},{"key":"10.1016\/j.tem.2026.05.004_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.105691","article-title":"FOXS1 is increased in liver fibrosis and regulates TGF\u03b2 responsiveness and proliferation pathways in human hepatic stellate cells","volume":"300","author":"Bates","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2026.05.004_bb0035","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1152\/physrev.00021.2023","article-title":"Glucocorticoids, their uses, sexual dimorphisms, and diseases: new concepts, mechanisms, and discoveries","volume":"104","author":"Martinez","year":"2024","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tem.2026.05.004_bb0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1749-6632.2012.06633.x","article-title":"Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction","volume":"1261","author":"Silverman","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tem.2026.05.004_bb0045","article-title":"Metabolites and metabolic pathways associated with glucocorticoid resistance in pregnant African-American women","volume":"1\u20132","author":"Corwin","year":"2020","journal-title":"Compr. Psychoneuroendocrinol."},{"key":"10.1016\/j.tem.2026.05.004_bb0050","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1073\/pnas.1118355109","article-title":"Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk","volume":"109","author":"Cohen","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2026.05.004_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413295","article-title":"Role of endothelial glucocorticoid receptor in the pathogenesis of kidney diseases","volume":"22","author":"Przybyci\u0144ski","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2026.05.004_bb0060","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.1007\/s11010-025-05379-9","article-title":"Inflammation in cardiovascular-kidney-metabolic syndrome: key roles and underlying mechanisms-a comprehensive review","volume":"480","author":"Xu","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.tem.2026.05.004_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.102344","article-title":"Cardiovascular-Kidney-Metabolic (CKM) syndrome: a state-of-the-art review","volume":"49","author":"Sebastian","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.tem.2026.05.004_bb0070","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2026.05.004_bb0075","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14744\/AnatolJCardiol.2025.5602","article-title":"From metabolic syndrome to cardiovascular-kidney-metabolic syndrome and systemic metabolic disorder: a call to recognize the progressive multisystemic dysfunction","volume":"29","author":"\u00d6zy\u00fcnc\u00fc","year":"2025","journal-title":"Anatol. J. Cardiol."},{"key":"10.1016\/j.tem.2026.05.004_bb0080","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/ijms22020623","article-title":"Molecular mechanisms of glucocorticoid-induced insulin resistance","volume":"22","author":"Beaupere","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2026.05.004_bb0085","doi-asserted-by":"crossref","first-page":"E249","DOI":"10.1152\/ajpendo.00478.2015","article-title":"The glucocorticoid receptor: cause of or cure for obesity?","volume":"310","author":"John","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2026.05.004_bb0090","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/384860","article-title":"Involvement of the androgen and glucocorticoid receptors in bladder cancer","volume":"2015","author":"McBeth","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.tem.2026.05.004_bb0095","doi-asserted-by":"crossref","first-page":"42911","DOI":"10.1074\/jbc.M111.311662","article-title":"Protein phosphatase 5 mediates lipid metabolism through reciprocal control of glucocorticoid receptor and peroxisome proliferator-activated receptor-gamma (PPAR\u03b3)","volume":"286","author":"Hinds","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2026.05.004_bb0100","doi-asserted-by":"crossref","first-page":"27313","DOI":"10.18632\/oncotarget.8430","article-title":"Glucocorticoid receptor beta increases migration of human bladder cancer cells","volume":"7","author":"McBeth","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.tem.2026.05.004_bb0105","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf1003","article-title":"The multimerization pathway of the glucocorticoid receptor","volume":"53","author":"Alegre-Mart\u00ed","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tem.2026.05.004_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108363","article-title":"Steroid receptors and coregulators: dissemination of sex differences and emerging technologies","volume":"301","author":"Pauss","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2026.05.004_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2024.100741","article-title":"Selective modulation of the human glucocorticoid receptor compromises GR chromatin occupancy and recruitment of p300\/CBP and the mediator complex","volume":"23","author":"Van Moortel","year":"2024","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.tem.2026.05.004_bb0120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrm.2016.152","article-title":"Glucocorticoid receptor control of transcription: precision and plasticity via allostery","volume":"18","author":"Weikum","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tem.2026.05.004_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.572981","article-title":"Multifaceted control of GR signaling and its impact on hepatic transcriptional networks and metabolism","volume":"11","author":"Pr\u00e6stholm","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.tem.2026.05.004_bb0130","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.3390\/ijms22116054","article-title":"Mitochondrial glucocorticoid receptors and their actions","volume":"22","author":"Kokkinopoulou","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2026.05.004_bb0135","series-title":"StatPearls","article-title":"Physiology, adrenal gland","author":"Dutt","year":"2026"},{"key":"10.1016\/j.tem.2026.05.004_bb0140","series-title":"StatPearls","article-title":"Physiology, glucocorticoids","author":"Chourpiliadis","year":"2026"},{"key":"10.1016\/j.tem.2026.05.004_bb0145","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1038\/s41467-022-32905-w","article-title":"Sirtuin 6 inhibition protects against glucocorticoid-induced skeletal muscle atrophy by regulating IGF\/PI3K\/AKT signaling","volume":"13","author":"Mishra","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2026.05.004_bb0150","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3390\/ijms23020661","article-title":"Glucocorticoid regulates the synthesis of porcine muscle protein through m6A modified amino acid transporter SLC7A7","volume":"23","author":"Xu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2026.05.004_bb0155","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/ijms17020232","article-title":"Overexpression of glucocorticoid receptor \u03b2 enhances myogenesis and reduces catabolic gene expression","volume":"17","author":"Hinds","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2026.05.004_bb0160","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S2213-8587(25)00251-7","article-title":"Glucocorticoid-induced osteoporosis: novel concepts and clinical implications","volume":"13","author":"Hofbauer","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.tem.2026.05.004_bb0165","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41423-020-0477-9","article-title":"Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrine","volume":"17","author":"Capellino","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.tem.2026.05.004_bb0170","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.bbi.2020.03.012","article-title":"Glucocorticoids prime the inflammatory response of human hippocampal cells through up-regulation of inflammatory pathways","volume":"87","author":"Horowitz","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.tem.2026.05.004_bb0175","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1038\/s41467-023-38456-y","article-title":"Dasatinib overcomes glucocorticoid resistance in B-cell acute lymphoblastic leukemia","volume":"14","author":"Sarno","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2026.05.004_bb0180","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1038\/s41467-024-48818-9","article-title":"Glucocorticoids paradoxically promote steroid resistance in B cell acute lymphoblastic leukemia through CXCR4\/PLC signaling","volume":"15","author":"Abdoul-Azize","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2026.05.004_bb0185","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1038\/s41375-021-01291-5","article-title":"MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance","volume":"35","author":"van der Zwet","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.tem.2026.05.004_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101751","article-title":"Pharmacological inhibition of lipolysis prevents adverse metabolic outcomes during glucocorticoid administration","volume":"74","author":"Linden","year":"2023","journal-title":"Mol. Metab."},{"key":"10.1016\/j.tem.2026.05.004_bb0195","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/s41467-024-45477-8","article-title":"Glucocorticoids increase adiposity by stimulating Kr\u00fcppel-like factor 9 expression in macrophages","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2026.05.004_bb0200","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fendo.2020.00059","article-title":"Glucocorticoid metabolism in obesity and following weight loss","volume":"11","author":"Akalestou","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.tem.2026.05.004_bb0205","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.molmet.2017.06.013","article-title":"Adipocyte glucocorticoid receptor is important in lipolysis and insulin resistance due to exogenous steroids, but not insulin resistance caused by high fat feeding","volume":"6","author":"Shen","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.tem.2026.05.004_bb0210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2337\/db23-0165","article-title":"Adipocyte glucocorticoid receptor activation with high glucocorticoid doses impairs healthy adipose tissue expansion by repressing angiogenesis","volume":"73","author":"Vali","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2026.05.004_bb0215","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1042\/CS20242825","article-title":"Heme oxygenase, biliverdin reductase, and bilirubin pathways regulate oxidative stress and insulin resistance: a focus on diabetes and therapeutics","volume":"139","author":"Lee","year":"2025","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.tem.2026.05.004_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155607","article-title":"Hepatic insulin receptor: new views on the mechanisms of liver disease","volume":"145","author":"Lee","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.tem.2026.05.004_bb0225","doi-asserted-by":"crossref","first-page":"25776","DOI":"10.1074\/jbc.M116.752311","article-title":"Glucocorticoid receptor \u03b2 induces hepatic steatosis by augmenting inflammation and inhibition of the peroxisome proliferator-activated receptor (PPAR) \u03b1","volume":"291","author":"Marino","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2026.05.004_bb0230","doi-asserted-by":"crossref","DOI":"10.1152\/physiol.2023.38.S1.5733222","article-title":"Glucocorticoid receptor-beta (GRb) is a driver of adiposity via PPARgamma in adipose tissue: lessons learned from the first CRISPR GRb KO animals","volume":"38","author":"Martinez","year":"2023","journal-title":"Physiology"},{"key":"10.1016\/j.tem.2026.05.004_bb0235","article-title":"Novel genetic variants of PPAR\u03b32 promoter in gestational diabetes mellitus and its molecular regulation in adipogenesis","volume":"11","author":"Wu","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.tem.2026.05.004_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2024.106840","article-title":"Glucocorticoid resistance remodels liver lipids and prompts lipogenesis, eicosanoid, and inflammatory pathways","volume":"173","author":"Martinez","year":"2024","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.tem.2026.05.004_bb0245","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4810672","article-title":"Deciphering the roles of thiazolidinediones and PPAR\u03b3 in bladder cancer","volume":"2017","author":"Chiu","year":"2017","journal-title":"PPAR Res."},{"key":"10.1016\/j.tem.2026.05.004_bb0250","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.metabol.2015.02.005","article-title":"Thiazolidinediones attenuate lipolysis and ameliorate dexamethasone-induced insulin resistance","volume":"64","author":"He","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.tem.2026.05.004_bb0255","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/10253890.2019.1658736","article-title":"Glucocorticoids regulate adipose tissue protein concentration in a depot- and sex-specific manner","volume":"23","author":"Hill","year":"2020","journal-title":"Stress"},{"key":"10.1016\/j.tem.2026.05.004_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2026.156573","article-title":"Sex differences in cardiovascular-kidney-metabolic syndrome and new onset cardiovascular outcomes","volume":"179","author":"Liu","year":"2026","journal-title":"Metabolism"},{"key":"10.1016\/j.tem.2026.05.004_bb0265","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.2337\/db22-0605","article-title":"Chronic glucocorticoid exposure induced an S1PR2-ROR\u03b3 axis to enhance hepatic gluconeogenesis in male mice","volume":"72","author":"Lee","year":"2023","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2026.05.004_bb0270","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.metabol.2005.01.030","article-title":"Antisense oligonucleotides targeted against glucocorticoid receptor reduce hepatic glucose production and ameliorate hyperglycemia in diabetic mice","volume":"54","author":"Liang","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.tem.2026.05.004_bb0275","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1210\/me.2003-0283","article-title":"Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus","volume":"18","author":"Opherk","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.tem.2026.05.004_bb0280","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93378-3","article-title":"Chronic glucocorticoid treatment induces hepatic lipid accumulation and hyperinsulinaemia in part through actions on AgRP neurons","volume":"11","author":"Harno","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2026.05.004_bb0285","doi-asserted-by":"crossref","first-page":"E995","DOI":"10.1152\/ajpendo.00516.2019","article-title":"Long-term hypercortisolism induces lipogenesis promoting palmitic acid accumulation and inflammation in visceral adipose tissue compared with HFD-induced obesity","volume":"318","author":"Garc\u00eda-Eguren","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2026.05.004_bb0290","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/ATVBAHA.124.320744","article-title":"Prostaglandins and the cardiovascular system","volume":"45","author":"Ricciotti","year":"2025","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tem.2026.05.004_bb0295","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00424-022-02715-6","article-title":"Role of glucocorticoid receptor mutations in hypertension and adrenal gland hyperplasia","volume":"474","author":"Verouti","year":"2022","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.tem.2026.05.004_bb0300","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/01.HYP.30.5.1274","article-title":"Impaired cortisol binding to glucocorticoid receptors in hypertensive patients","volume":"30","author":"Mulatero","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2026.05.004_bb0305","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00424-024-03014-y","article-title":"Salt-sensitive hypertension in GR mutant rats is associated with altered plasma polyunsaturated fatty acid levels and aortic vascular reactivity","volume":"477","author":"Verouti","year":"2025","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.tem.2026.05.004_bb0310","first-page":"109","article-title":"Glucocorticoids induce cardiac fibrosis via mineralocorticoid receptor in oxidative stress: contribution of elongation factor eleven-nineteen lysine-rich leukemia (ELL)","volume":"57","author":"Omori","year":"2014","journal-title":"Yonago Acta. Med."},{"key":"10.1016\/j.tem.2026.05.004_bb0315","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/HYPERTENSIONAHA.123.21358","article-title":"Mineralocorticoid receptors in vascular smooth muscle: blood pressure and beyond","volume":"81","author":"Camarda","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2026.05.004_bb0320","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2026.05.004_bb0325","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2026.05.004_bb0330","doi-asserted-by":"crossref","first-page":"e1206","DOI":"10.1210\/clinem\/dgaa896","article-title":"Effects of obesity and insulin on tissue-specific recycling between cortisol and cortisone in men","volume":"106","author":"Anderson","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2026.05.004_bb0335","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11695-009-9937-0","article-title":"Overexpression of 11\u03b2-hydroxysteroid dehydrogenase type 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients","volume":"20","author":"Baudrand","year":"2010","journal-title":"Obes. Surg."},{"key":"10.1016\/j.tem.2026.05.004_bb0340","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1053\/j.gastro.2021.05.008","article-title":"Associations among adipose tissue immunology, inflammation, exosomes and insulin sensitivity in people with obesity and nonalcoholic fatty liver disease","volume":"161","author":"Fuchs","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2026.05.004_bb0345","doi-asserted-by":"crossref","first-page":"8984","DOI":"10.3390\/ijms23168984","article-title":"11\u03b2-HSD as a new target in pharmacotherapy of metabolic diseases","volume":"23","author":"Kupczyk","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2026.05.004_bb0350","article-title":"Cortisol excess in chronic kidney disease \u2013 a review of changes and impact on mortality","volume":"13","author":"Sagmeister","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.tem.2026.05.004_bb0355","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ando.2022.04.004","article-title":"Role of insulin resistance on fertility \u2013 focus on polycystic ovary syndrome","volume":"83","author":"Vatier","year":"2022","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"10.1016\/j.tem.2026.05.004_bb0360","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-25941-1","article-title":"11\u03b2-HSD1 inhibitor alleviates lipid metabolism disorder by activating the AMPK signaling pathway","volume":"15","author":"Han","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2026.05.004_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2025.106882","article-title":"Excess aldosterone and cortisol promote myocardial iron deficiency: a potential pathway to cardiac injury","volume":"255","author":"Cirovic","year":"2026","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.tem.2026.05.004_bb0370","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1161\/HYPERTENSIONAHA.120.16458","article-title":"Decreased 11\u03b2-hydroxysteroid dehydrogenase type 2 expression in the kidney may contribute to nicotine\/smoking-induced blood pressure elevation in mice","volume":"77","author":"Wang","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2026.05.004_bb0375","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1210\/clinem\/dgae663","article-title":"Progressive 11\u03b2-hydroxysteroid dehydrogenase type 2 insufficiency as kidney function declines","volume":"110","author":"Uslar","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2026.05.004_bb0380","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1097\/HJH.0000000000004159","article-title":"Novel homozygous pathogenic variant in HSD11B2 as a cause of apparent mineralocorticoid excess","volume":"43","author":"Roche-Gomez","year":"2025","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2026.05.004_bb0385","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jphs.2024.02.001","article-title":"JTT-654, an 11-beta hydroxysteroid dehydrogenase type 1 inhibitor, improves hypertension and diabetic kidney injury by suppressing angiotensinogen production","volume":"154","author":"Heitaku","year":"2024","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.tem.2026.05.004_bb0390","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41574-025-01209-6","article-title":"Driving hypertension: non-classic apparent mineralocorticoid excess","volume":"22","author":"Carvajal","year":"2025","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tem.2026.05.004_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.numecd.2025.104191","article-title":"Mineralocorticoid receptor regulates vascular damage by inducing autophagy in mice with obesity and hypertension","volume":"35","author":"Wang","year":"2025","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.tem.2026.05.004_bb0400","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1161\/HYPERTENSIONAHA.116.08966","article-title":"Renal dysfunction induced by kidney-specific gene deletion of Hsd11b2 as a primary cause of salt-dependent hypertension","volume":"70","author":"Ueda","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2026.05.004_bb0405","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/HJH.0b013e328340aa18","article-title":"Prenatal overexposure to glucocorticoids programs renal 11\u03b2-hydroxysteroid dehydrogenase type 2 expression and salt-sensitive hypertension in the rat","volume":"29","author":"Tang","year":"2011","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2026.05.004_bb0410","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.3390\/ijms22073649","article-title":"Glucocorticoid receptor \u03b2 (GR\u03b2): beyond its dominant-negative function","volume":"22","author":"Ramos-Ram\u00edrez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2026.05.004_bb0415","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.tem.2021.08.003","article-title":"FKBP51 and the molecular chaperoning of metabolism","volume":"32","author":"Smedlund","year":"2021","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2026.05.004_bb0420","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.3390\/ijms23063322","article-title":"Crosstalk between p38 MAPK and GR signaling","volume":"23","author":"Zeyen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2026.05.004_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.114206","article-title":"NF-\u03baB-dependent GR cistrome redistribution recruits GR to inflammatory genes but correlates with lesser glucocorticoid-mediated repression","volume":"28","author":"Mostafa","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.tem.2026.05.004_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173861","article-title":"GR\/NF-\u03baB signaling pathway regulates hippocampal inflammatory responses in diabetic rats with chronic unpredictable mild stress","volume":"895","author":"Li","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tem.2026.05.004_bb0435","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98276-2","article-title":"Role of hypothalamic-pituitary adrenal-axis, toll-like receptors, and macrophage polarization in pre-atherosclerotic changes induced by social isolation stress in mice","volume":"11","author":"Haj-Mirzaian","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2026.05.004_bb0440","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00280-020-04122-z","article-title":"miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway","volume":"86","author":"Lucaf\u00f2","year":"2020","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.tem.2026.05.004_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221810049","article-title":"Glucocorticoid resistance: interference between the glucocorticoid receptor and the MAPK signalling pathways","volume":"22","author":"Sevilla","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2026.05.004_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188430","article-title":"Latest perspectives on glucocorticoid-induced apoptosis and resistance in lymphoid malignancies","volume":"1874","author":"Clarisse","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.tem.2026.05.004_bb0455","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.molimm.2023.09.002","article-title":"Suppression of mir-150-5p attenuates the anti-inflammatory effect of glucocorticoids in mice with ulcerative colitis","volume":"163","author":"Wang","year":"2023","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.tem.2026.05.004_bb0460","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsbmb.2008.11.006","article-title":"Targeted ablation reveals a novel role of FKBP52 in gene-specific regulation of glucocorticoid receptor transcriptional activity","volume":"113","author":"Wolf","year":"2009","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.tem.2026.05.004_bb0465","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1210\/en.2009-1158","article-title":"Susceptibility to diet-induced hepatic steatosis and glucocorticoid resistance in FK506-binding protein 52-deficient mice","volume":"151","author":"Warrier","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2026.05.004_bb0470","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s11010-022-04591-1","article-title":"The emerging importance of immunophilins in fibrosis development","volume":"478","author":"Alqudah","year":"2023","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.tem.2026.05.004_bb0475","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/s41594-023-01128-y","article-title":"Cryo-EM reveals how Hsp90 and FKBP immunophilins co-regulate the glucocorticoid receptor","volume":"30","author":"Noddings","year":"2023","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.tem.2026.05.004_bb0480","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92039-9","article-title":"Glucocorticoid resistance conferring mutation in the C-terminus of GR alters the receptor conformational dynamics","volume":"11","author":"Kaziales","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2026.05.004_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2022.106068","article-title":"Glucocorticoid receptor gene mutations confer glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia","volume":"218","author":"Tamai","year":"2022","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.tem.2026.05.004_bb0490","first-page":"858","article-title":"Glucocorticoid receptor polymorphisms in rheumatoid arthritis: results from a single centre","volume":"38","author":"Bazs\u00f3","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.tem.2026.05.004_bb0495","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1007\/s10072-020-04376-8","article-title":"Glucocorticoid receptor mutations and clinical sensitivity to glucocorticoid in Chinese multiple sclerosis patients","volume":"41","author":"Song","year":"2020","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.tem.2026.05.004_bb0500","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00592-021-01799-3","article-title":"A 646C > G (rs41423247) polymorphism of the glucocorticoid receptor as a risk factor for hyperglycaemia diagnosed in pregnancy-data from an observational study","volume":"59","author":"Zawiejska","year":"2022","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.tem.2026.05.004_bb0505","doi-asserted-by":"crossref","DOI":"10.1172\/JCI190180","article-title":"The human glucocorticoid receptor variant rs6190 increases blood cholesterol and promotes atherosclerosis","volume":"135","author":"Durumutla","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2026.05.004_bb0510","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-07398-4","article-title":"Impact of glucocorticoid receptor polymorphism rs6198 on sepsis survival in a prospective multicenter cohort","volume":"15","author":"Sombetzki","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2026.05.004_bb0515","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/medicina58101475","article-title":"An update on the current and emerging use of thiazolidinediones for type 2 diabetes","volume":"58","author":"Giglio","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.tem.2026.05.004_bb0520","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/eurheartj\/ehaa736","article-title":"Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine","volume":"42","author":"Agarwal","year":"2021","journal-title":"Eur. Heart J."}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276026001232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276026001232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:07:54Z","timestamp":1783109274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276026001232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":104,"alternative-id":["S1043276026001232"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2026.05.004","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucocorticoid resistance-induced inflammation drives cardiovascular\u2013kidney\u2013metabolic (CKM) syndrome pathophysiology","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2026.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}